WahanaRiau.com - Philogen

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Philogen

Index

Globenewswire

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Senin, 16 Oktober 2023 - 22:07:00 Wib

Philogen

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Terpopuler

C-Hawk Expands Southeast Asia Manufacturing Capabilities and Capacity with New Malaysia and Vietnam Facilities
Dibaca: 160 Kali

MP & Silva wins the dispute with Chinese group Everbright
Dibaca: 220 Kali

Bitget Expands Agent Hub Ecosystem Through MuleRun Partnership to Advance Agentic Trading
Dibaca: 147 Kali

Omni Bridgeway Appoints Peter Galgay as Head of Commercial Strategy and Capital Solutions
Dibaca: 194 Kali

Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Dibaca: 165 Kali

Terkini

DHL Express appoints new commercial lead for Asia Pacific

Lee Kum Kee Celebrates Culinary Excellence at the Historic Hong Kong Debut of Asia’s 50 Best Restaurants 2026

Alibaba Unveils Qwen3.6-Plus to Accelerate Agentic AI Deployment for Enterprises and Alibaba’s AI Applications

Organizations Overlook AI Risk as Governance Fails to Keep Up

SonicWall Reframes Annual Research Around SMB Protection Outcomes, Reveals the Seven Deadly Sins in 2026 Cyber Protect Report

Philogen

Nidlegy™ Phase III PIVOTAL Trial Meets the Study’s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Terpopuler

C-Hawk Expands Southeast Asia Manufacturing Capabilities and Capacity with New Malaysia and Vietnam Facilities Dibaca: 160 Kali

MP & Silva wins the dispute with Chinese group Everbright Dibaca: 220 Kali

Bitget Expands Agent Hub Ecosystem Through MuleRun Partnership to Advance Agentic Trading Dibaca: 147 Kali

Omni Bridgeway Appoints Peter Galgay as Head of Commercial Strategy and Capital Solutions Dibaca: 194 Kali

Zymeworks Appoints Kristin Stafford as Chief Financial Officer Dibaca: 165 Kali

Terkini

DHL Express appoints new commercial lead for Asia Pacific

Lee Kum Kee Celebrates Culinary Excellence at the Historic Hong Kong Debut of Asia’s 50 Best Restaurants 2026

Alibaba Unveils Qwen3.6-Plus to Accelerate Agentic AI Deployment for Enterprises and Alibaba’s AI Applications

Organizations Overlook AI Risk as Governance Fails to Keep Up

SonicWall Reframes Annual Research Around SMB Protection Outcomes, Reveals the Seven Deadly Sins in 2026 Cyber Protect Report

C-Hawk Expands Southeast Asia Manufacturing Capabilities and Capacity with New Malaysia and Vietnam Facilities
Dibaca: 160 Kali

MP & Silva wins the dispute with Chinese group Everbright
Dibaca: 220 Kali

Bitget Expands Agent Hub Ecosystem Through MuleRun Partnership to Advance Agentic Trading
Dibaca: 147 Kali

Omni Bridgeway Appoints Peter Galgay as Head of Commercial Strategy and Capital Solutions
Dibaca: 194 Kali

Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Dibaca: 165 Kali